To view this email as a web page, click here.

TOP STORIES
 
New strategies for managing drug spend: RA, Cancer, Hep C
The proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
Read more
 
Five pharmacy regulations health execs must keep on their radars in 2017
Here are five critical regulations that executives can begin to prepare for today.
Read more
 
Study: More resources needed for medication-assisted treatment
A new study has interesting findings.
Read more
ADVERTISEMENT
Converge Connect Collaborate
Asembia's annual Specialty Pharmacy Summit returns to Wynn and Encore in Las Vegas from April 30 through May 3, 2017. The agenda features four full days of business workshops, educational seminars, exhibitor hall, and continuing education credits, along with a host of networking and social events. For more information or to register, visit www.asembiasummit.com
 
 
DIGITAL EDITION
Check out our latest issue featuring
 • Four priorities to thrive in the future
 • Six diseases reap benefits of genetic tests
 • Critical tech tools to offer members
 • Cannabinoid-based drug pipeline
Read more
ADVERTISEMENT
All Healthcare is not Local: The Human Cost of Disparate Health Data
To address rising healthcare costs, clinicians have experienced countless shifting demands and requirements over the past decade. While there's no single solution to address all of the issues that contribute to rising costs, improving care coordination across the healthcare continuum has the potential to dramatically improve patient care, reduce duplicative tests and procedures, and positively impact care quality – saving an estimated $148 billion to $226 billion annually.
A truly national record locator service breaks down the barriers to patient data by providing the ability to find, request and receive vital patient health information from outside systems within providers' existing EHR workflow. Learn More
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.